If Gavi is to deliver on its mission, it must take some risk, and do everything possible to mitigate that risk. Donors realise this, but also rightly expect risks to be minimised and action to be taken when misuse is uncoveredDownload the policy
The goal of Gavi’s transparency and accountability policy is to ensure that all Gavi support at country level is managed in a transparent and accountable manner through systems that include appropriate oversight mechanisms, and that the support is used according to the programme objectives as outlined in individual country agreements.
The policy governs the transparency and accountability aspects of Gavi support provided in the form of cash, vaccines and vaccine devices at country level. Vaccine (and vaccine device) oversight will focus on cases of misuse and not on issues relating to supply chain efficiency and wastage.
What are the principles governing the transparency and accountability policy?
The policy aims to retain a flexible and non-prescriptive approach to allow for differences in country contexts. Guidance on implementation will be provided to countries through the Secretariat and in-country partners, as relevant. The policy enhances continued efforts by Gavi to support sustainable development of country capacity and systems.
On January 1, 2009, Gavi enacted its first transparency and accountability policy that governed the management of all cash-based support to Gavi eligible countries.
The policy was reviewed during 2013 through a Secretariat led process that included a desk review of the documented experiences to date, consultations with countries (both through in-depth case studies and through questionnaires distributed to countries), donors and other stakeholders, and a benchmarking exercise. As a result of this review the Gavi Board approved a revised policy in November 2013.
The main changes between the original and the revised policy are: adjustments to the goal to include vaccines in the scope of the transparency and accountability policy, adjustments in the principles (to include prevention), the removal of implementation details and country categorisation (removal of the procedures section in original policy) and the addition of separate sections on risk assessments, cash programmes, vaccines and a misuse/suspected misuse and corrective actions section.
The revised policy took effect on 1 January 2014. The next review of the policy will take place in 2019.